These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 24058074)
1. Current treatment and outcome of coronary in-stent restenosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Schwalm T; Carlsson J; Meissner A; Lagerqvist B; James S EuroIntervention; 2013 Sep; 9(5):564-72. PubMed ID: 24058074 [TBL] [Abstract][Full Text] [Related]
2. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Sarno G; Lagerqvist B; Fröbert O; Nilsson J; Olivecrona G; Omerovic E; Saleh N; Venetzanos D; James S Eur Heart J; 2012 Mar; 33(5):606-13. PubMed ID: 22232428 [TBL] [Abstract][Full Text] [Related]
3. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis. Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881 [TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry. Kutcher MA; Brennan JM; Rao SV; Dai D; Anstrom KJ; Mustafa N; Sedrakyan A; Booth ME; Douglas PS; Messenger JC Catheter Cardiovasc Interv; 2014 Feb; 83(2):171-81. PubMed ID: 23907981 [TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry. Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G; EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062 [TBL] [Abstract][Full Text] [Related]
7. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents. Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ; Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097 [TBL] [Abstract][Full Text] [Related]
8. One-year outcomes with angiographic follow-up of paclitaxel-eluting balloon for the treatment of in-stent restenosis: insights from Spanish multicenter registry. Vaquerizo B; Serra A; Miranda-Guardiola F; Martínez V; Antoni Gómez-Hospital J; Iñiguez A; Fernández E; Ramón Rumoroso J; Bosa F; Otaegui I J Interv Cardiol; 2011 Dec; 24(6):518-28. PubMed ID: 21917013 [TBL] [Abstract][Full Text] [Related]
9. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341 [TBL] [Abstract][Full Text] [Related]
10. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry. Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528 [TBL] [Abstract][Full Text] [Related]
11. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention. Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511 [TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis. Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ; JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-eluting balloon versus everolimus-eluting stent for treatment of drug-eluting stent restenosis. Almalla M; Schröder J; Pross V; Marx N; Hoffmann R Catheter Cardiovasc Interv; 2014 May; 83(6):881-7. PubMed ID: 23765557 [TBL] [Abstract][Full Text] [Related]
14. Initial clinical experience with an everolimus eluting platinum chromium stent (Promus Element) in unselected patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Sarno G; Lagerqvist B; Carlsson J; Olivecrona G; Nilsson J; Calais F; Götberg M; Nilsson T; Sjögren I; James S Int J Cardiol; 2013 Jul; 167(1):146-50. PubMed ID: 22244480 [TBL] [Abstract][Full Text] [Related]
15. Clinical and angiographic outcomes of bioabsorbable vs. permanent polymer drug-eluting stents in Sweden: a report from the Swedish Coronary and Angioplasty Registry (SCAAR). Buccheri S; James S; Lindholm D; Fröbert O; Olivecrona GK; Persson J; Hambraeus K; Witt N; Erlinge D; Angerås O; Lagerqvist B; Sarno G Eur Heart J; 2019 Aug; 40(31):2607-2615. PubMed ID: 31079155 [TBL] [Abstract][Full Text] [Related]
16. Proximal coronary artery intervention: stent thrombosis, restenosis and death. Calais F; Lagerqvist B; Leppert J; James SK; Fröbert O Int J Cardiol; 2013 Dec; 170(2):227-32. PubMed ID: 24211065 [TBL] [Abstract][Full Text] [Related]
17. Implantation of a drug-eluting stent with a different drug (switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent]). Alfonso F; Pérez-Vizcayno MJ; Dutary J; Zueco J; Cequier A; García-Touchard A; Martí V; Lozano I; Angel J; Hernández JM; López-Mínguez JR; Melgares R; Moreno R; Seidelberger B; Fernández C; Hernandez R; JACC Cardiovasc Interv; 2012 Jul; 5(7):728-37. PubMed ID: 22814777 [TBL] [Abstract][Full Text] [Related]
18. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group. Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA; JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052 [TBL] [Abstract][Full Text] [Related]
19. The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry. Abizaid A; Costa JR; Banning A; Bartorelli AL; Dzavik V; Ellis S; Gao R; Holmes DR; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Orlick A; Spaulding C; Worthley S; Urban PM; JACC Cardiovasc Interv; 2012 Jan; 5(1):64-71. PubMed ID: 22230152 [TBL] [Abstract][Full Text] [Related]
20. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry. Jensen JK; Jensen LO; Terkelsen CJ; Lassen JF; Tilsted HH; Hansen KN; Maeng M; Thuesen L; Thayssen P Catheter Cardiovasc Interv; 2013 Feb; 81(2):260-5. PubMed ID: 22511512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]